SEC Tracker
Get the app

UiPath PATH

UiPath Q2 FY27: revenue $410.3M, up 13%; diluted EPS $0.07

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers UiPath reported for Q2 FY27, the quarter ended Jul 31, 2026, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$410.3M+13% from $361.7M in Q2 FY2610-Q income statement, on EDGAR
  2. Net income$36.1M+2178% from $1.6M in Q2 FY2610-Q income statement, on EDGAR
  3. Diluted EPS$0.07Against $0.00 in Q2 FY2610-Q income statement, on EDGAR
  4. Cash and cash equivalents$607.4M−3% from $628.6M in Q2 FY26Cash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
  5. Cash from operations$30.7M−26% from $41.6M in Q2 FY2610-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when UiPath files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 7372 and related industry codes: the same peer list as the financial tables.

  1. BILL Holdings BILL public float $4.8B, Dec 31, 2025
  2. Klaviyo KVYO public float $4.8B, Jun 30, 2025
  3. Life360 LIF public float $4.8B, Jun 30, 2025
  4. Pegasystems PEGA public float $5.0B, Jun 30, 2025
  5. Science Applications International SAIC public float $5.0B, Aug 1, 2025